Navigation Links
3-D monitor vision test Developed for Children

Stereopsis in children older than three years will soon be assessed by a new random-dot stereotest using a 3D display and infrared oculography according to an article published in the November 2006 // issue of Investigative Ophthalmology & Visual Science (IOVS).

The study involved 56 children, 38 with various visual impairments and 18 with normal vision. Study participants were seated on their mother's lap or alone with their heads stabilized by a chin and front rest. Unlike a number of other tests, this new 3D monitor stereotest does not require disassociating glasses that children often find cumbersome. The random dot stimulus was presented on an autostereoscopic display which allows viewing of full-color 3D images. The stimulus recognition was objectively assessed using infrared photo-oculography. The overall accuracy of the test was found to be 95 percent.

If applicable to preverbal children, the new test may permit study of the development of stereovision under natural conditions since no glasses are necessary to see the stimuli. The new test may be useful for the objective measurement of the sensory outcome following the treatment of ophthalmic disorders in the pediatric age group. It is also a potential substitute for the Lang I and II Test and the Radom-dot E Test, which require verbal capabilities from the subject tested.

Source-Eurekalert
NLA
'"/>




Page: 1

Related medicine news :

1. Way to monitor blood pressure
2. Microscopic lens monitors heart problems
3. Pharmaceutical industries grant for R&D to be monitored
4. GRIP a boon for the nurses to monitor patients glucose levels.
5. FDA needs to be more vigilant in monitoring, tissue banks.
6. Yale School of Medicine Launches Telemonitoring Of Heart Failure Symptoms
7. Satellite Imagery to monitor the Social Impact Of Geographical Changes
8. Role of fats and oils in vision care
9. Watching television for long hours could lead to agressiveness
10. Body mass index guide needs revision
11. Putting cancer risk with a vision
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/28/2016)... VATICAN CITY (PRWEB) , ... April 28, 2016 ... ... medicine is on the world stage this week. A group of researchers and ... Conference on the Progress of Regenerative Medicine and Its Cultural Impact ” and ...
(Date:4/28/2016)... ... 28, 2016 , ... Head Over Heels Athletic Arts’ gymnast, Brooklyn Varize, has ... be held at the University of Montana on April 28-May 1. Varize will compete ... , In order to qualify, Varize needed to place top seven all-around in her ...
(Date:4/28/2016)... ... 2016 , ... Cosmetic Town, an online plastic surgery community, announces the relaunch ... recently revamped and upgraded to allow even more interaction between doctors and patients as ... According to the senior editor of Cosmetic Town, “We are excited that our ...
(Date:4/28/2016)... ... April 28, 2016 , ... In 2011, TIME magazine ... the emerging field of biomechatronics, technology that marries human physiology with electromechanics. He continues ... He is also the Founder of BionX , a leader in the field ...
(Date:4/28/2016)... ... ... One way to ignore solid evidence is to dismiss research because, “it ... baby out with the bathwater when we ignore all studies because some are fatally ... making better use of education policy research. , “When readers heed basic cautions, research ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... , Net Sales of $1.90 billion represent an increase ... period, and an increase of 1.2% on an adjusted pro ... first quarter were $0.52 reported, a decrease of 47.5% from ... 29.9% over the prior year period , The Company ... Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) ...
(Date:4/28/2016)... 2016 TapImmune,Inc. (TPIV), a ... and gene-based immunotherapeutics and vaccines for the treatment of cancer ... the 3rd Annual Growth Capital Expo to be ... at Caesars Palace in Las Vegas, Nevada.  The Company ... 4 th by Dr. John N. Bonfiglio ...
(Date:4/27/2016)... , April 27, 2016   ... 42% Growth in Recurring Consumable Sales  Clinical ... Mauna Kea Technologies (Euronext: MKEA, OTCQX: MKEAY) inventor of ... its sales for the first quarter ended March 31, ... the execution of its commercial strategy. First ...
Breaking Medicine Technology: